Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 808 of 808 entries
View as:

An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma

Phase: N/A Priority: Normal
NCT ID: NCT02648997 Org: User:
Start: 03/31/16 End: 12/01/25 Due: 12/01/26

A Study Of Pembrolizumab In Combination With Trastuzumab-DM1

Phase: N/A Priority: Normal
NCT ID: NCT03032107 Org: User:
Start: 02/17/17 End: 12/05/24 Due: 12/05/25

Videos for Advance Care Planning in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT04149704 Org: User:
Start: 12/13/19 End: 05/05/22 Due: 05/05/23

Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT03716739 Org: User:
Start: 03/19/19 End: 03/01/26 Due: 03/01/27

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05335434 Org: User:
Start: 06/10/22 End: 09/19/25 Due: 09/19/26

Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00925652 Org: User:
Start: 09/30/10 End: 01/30/19 Due: 01/30/20

A Phase II Trial of Regadenoson in Sickle Cell Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01788631 Org: User:
Start: 07/31/13 End: 12/12/16 Due: 12/12/17

NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01808417 Org: User:
Start: 06/21/13 End: 04/07/15 Due: 04/07/16